Compare Manhattan Associates Inc (MANH) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manhattan Associates Inc vs Summit Therapeutics Inc — how do they compare? Manhattan Associates Inc trades at $159.61 (market cap $9.79B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Manhattan Associates Inc and Summit Therapeutics Inc are close in size by market cap, and Manhattan Associates Inc is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| MANH | SMMT | |
|---|---|---|
Market Cap | $9.79B | $10.48B |
Sector | Technology | Health |
52-Week High | $227.94 | $29.32 |
52-Week Low | $120.88 | $13.05 |
Enterprise Value | $9.62B | $9.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Manhattan Associates Inc
Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.
Read more on MANH →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
